{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:16:35Z","timestamp":1792678595878,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88713-x","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T06:54:46Z","timestamp":1739343286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Global burden of vaccine-associated kidney injury using an international pharmacovigilance database"],"prefix":"10.1038","volume":"15","author":[{"given":"Hyeon Seok","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sug","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunghwan","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Seo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahhyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Il","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinseok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"88713_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1473-3099(17)30590-X","volume":"17","author":"The Lancet Infectious","year":"2017","unstructured":"The Lancet Infectious. The imperative of vaccination. Lancet Infect. Dis. 17, 1099. https:\/\/doi.org\/10.1016\/S1473-3099(17)30590-X (2017).","journal-title":"Lancet Infect. Dis."},{"key":"88713_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaci.2018.05.007","volume":"142","author":"ML Mallory","year":"2018","unstructured":"Mallory, M. L., Lindesmith, L. C. & Baric, R. S. Vaccination-induced herd immunity: successes and challenges. J. Allergy Clin. Immunol. 142, 64\u201366. https:\/\/doi.org\/10.1016\/j.jaci.2018.05.007 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"88713_CR3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/jama.2020.20895","volume":"324","author":"AN Desai","year":"2020","unstructured":"Desai, A. N. & Majumder, M. S. What Is Herd Immunity? JAMA 324, 2113 https:\/\/doi.org\/10.1001\/jama.2020.20895 (2020).","journal-title":"What Is Herd Immunity? JAMA"},{"key":"88713_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jama.2015.1518","volume":"313","author":"LO Gostin","year":"2015","unstructured":"Gostin, L. O. Law, ethics, and public health in the vaccination debates: politics of the measles outbreak. JAMA 313, 1099\u20131100. https:\/\/doi.org\/10.1001\/jama.2015.1518 (2015).","journal-title":"JAMA"},{"key":"88713_CR5","doi-asserted-by":"publisher","first-page":"9976","DOI":"10.1038\/s41598-023-36998-1","volume":"13","author":"M Kawabe","year":"2023","unstructured":"Kawabe, M. et al. Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients. Sci. Rep. 13, 9976. https:\/\/doi.org\/10.1038\/s41598-023-36998-1 (2023).","journal-title":"Sci. Rep."},{"key":"88713_CR6","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1038\/s41598-022-09897-0","volume":"12","author":"T Hamaya","year":"2022","unstructured":"Hamaya, T. et al. Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients. Sci. Rep. 12, 5876. https:\/\/doi.org\/10.1038\/s41598-022-09897-0 (2022).","journal-title":"Sci. Rep."},{"key":"88713_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.2021.0801","volume":"325","author":"CA Longhurst","year":"2021","unstructured":"Longhurst, C. A., Kremer, B. & Maysent, P. S. Rapid implementation of a Vaccination Superstation. JAMA 325, 931\u2013932. https:\/\/doi.org\/10.1001\/jama.2021.0801 (2021).","journal-title":"JAMA"},{"key":"88713_CR8","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl. J. Med. 383, 2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577 (2020).","journal-title":"N Engl. J. Med."},{"key":"88713_CR9","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.54724\/lc.2022.e15","volume":"2","author":"R Kwon","year":"2022","unstructured":"Kwon, R. & Rahmati, M. Global, regional, and national COVID-19 vaccination rate in 237 countries and territories, March 2022: a systematic analysis for World Health Organization COVID-19 dashboard, release 2. Life Cycle. 2, e15. https:\/\/doi.org\/10.54724\/lc.2022.e15 (2022).","journal-title":"Life Cycle"},{"key":"88713_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.vaccine.2018.11.045","volume":"37","author":"T Nakayama","year":"2019","unstructured":"Nakayama, T. Causal relationship between immunological responses and adverse reactions following vaccination. Vaccine 37, 366\u2013371. https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.045 (2019).","journal-title":"Vaccine"},{"key":"88713_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.anai.2022.01.026","volume":"129","author":"JM Kelso","year":"2022","unstructured":"Kelso, J. M. The adverse reactions to vaccines practice parameter 10 years on-what have we learned? Ann. Allergy Asthma Immunol. 129, 35\u201339. https:\/\/doi.org\/10.1016\/j.anai.2022.01.026 (2022).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"88713_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jaut.1999.0346","volume":"14","author":"Y Shoenfeld","year":"2000","unstructured":"Shoenfeld, Y. & Aron-Maor, A. Vaccination and autoimmunity-\u2018vaccinosis\u2019: a dangerous liaison? J. Autoimmun. 14, 1\u201310. https:\/\/doi.org\/10.1006\/jaut.1999.0346 (2000).","journal-title":"J. Autoimmun."},{"key":"88713_CR13","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S1473-3099(20)30130-4","volume":"20","author":"MZ Dudley","year":"2020","unstructured":"Dudley, M. Z. et al. The state of vaccine safety science: systematic reviews of the evidence. Lancet Infect. Dis. 20, e80\u2013e89. https:\/\/doi.org\/10.1016\/S1473-3099(20)30130-4 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"88713_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.kint.2021.04.035","volume":"100","author":"VD D\u2019Agati","year":"2021","unstructured":"D\u2019Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A. & Tartini, A. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney Int. 100, 461\u2013463. https:\/\/doi.org\/10.1016\/j.kint.2021.04.035 (2021).","journal-title":"Kidney Int."},{"key":"88713_CR15","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1097\/TP.0000000000004061","volume":"106","author":"SY Yoon","year":"2022","unstructured":"Yoon, S. Y., Sung, J. Y., Kim, J. S., Jeong, K. H. & Hwang, H. S. Acute kidney Injury with Endothelial Injury and Podocytopathy following COVID-19 vaccination. Transplantation 106, e236\u2013e237. https:\/\/doi.org\/10.1097\/TP.0000000000004061 (2022).","journal-title":"Transplantation"},{"key":"88713_CR16","doi-asserted-by":"publisher","unstructured":"Zhang, J., Cao, J. & Ye, Q. Renal side effects of COVID-19 vaccination. Vaccines (Basel). 10. https:\/\/doi.org\/10.3390\/vaccines10111783 (2022).","DOI":"10.3390\/vaccines10111783"},{"key":"88713_CR17","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.54724\/lc.2022.e13","volume":"2","author":"C Min","year":"2022","unstructured":"Min, C. The importance of a World Health Organization international pharmacovigilance database (VigiBase): novel methods for safety monitoring and surveillance of medical products. Life Cycle. 2, e13. https:\/\/doi.org\/10.54724\/lc.2022.e13 (2022).","journal-title":"Life Cycle"},{"key":"88713_CR18","doi-asserted-by":"publisher","unstructured":"Kim, M. S. et al. Hepatobiliary adverse drug reactions Associated with Remdesivir: the WHO International Pharmacovigilance Study. Clin. Gastroenterol. Hepatology: Official Clin. Pract. J. Am. Gastroenterological Association 19, 1970\u20131972 .e1973 (2021). https:\/\/doi.org\/10.1016\/j.cgh.2021.04.039","DOI":"10.1016\/j.cgh.2021.04.039"},{"key":"88713_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41467-021-27631-8","volume":"13","author":"LS Nguyen","year":"2022","unstructured":"Nguyen, L. S. et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat. Commun. 13, 25. https:\/\/doi.org\/10.1038\/s41467-021-27631-8 (2022).","journal-title":"Nat. Commun."},{"key":"88713_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate, A. et al. A bayesian neural network method for adverse drug reaction signal generation. Eur. J. Clin. Pharmacol. 54, 315\u2013321. https:\/\/doi.org\/10.1007\/s002280050466 (1998).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"88713_CR21","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1093\/eurheartj\/ehab362","volume":"42","author":"JE Salem","year":"2021","unstructured":"Salem, J. E. et al. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study. Eur. Heart J. 42, 3915\u20133928. https:\/\/doi.org\/10.1093\/eurheartj\/ehab362 (2021).","journal-title":"Eur. Heart J."},{"key":"88713_CR22","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.jacc.2019.07.056","volume":"74","author":"JE Salem","year":"2019","unstructured":"Salem, J. E. et al. Cardiovascular Toxicities Associated with Ibrutinib. J. Am. Coll. Cardiol. 74, 1667\u20131678. https:\/\/doi.org\/10.1016\/j.jacc.2019.07.056 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88713_CR23","doi-asserted-by":"publisher","unstructured":"Murthy, N. & Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States., MMWR. Morbidity and mortality weekly report 71, 229\u2013233 (2022). (2022). https:\/\/doi.org\/10.15585\/mmwr.mm7107a1","DOI":"10.15585\/mmwr.mm7107a1"},{"key":"88713_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.54724\/lc.2022.e1","volume":"2","author":"SW Lee","year":"2022","unstructured":"Lee, S. W. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2, e1. https:\/\/doi.org\/10.54724\/lc.2022.e1 (2022).","journal-title":"Life Cycle"},{"key":"88713_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12939-022-01750-0","volume":"21","author":"MS Nabaggala","year":"2022","unstructured":"Nabaggala, M. S. et al. The global inequity in COVID-19 vaccination coverage among health and care workers. Int. J. Equity Health. 21, 147. https:\/\/doi.org\/10.1186\/s12939-022-01750-0 (2022).","journal-title":"Int. J. Equity Health"},{"key":"88713_CR26","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1473-3099(21)00344-3","volume":"21","author":"T Burki","year":"2021","unstructured":"Burki, T. & Global COVID-19 vaccine inequity. Lancet Infect. Dis. 21, 922\u2013923. https:\/\/doi.org\/10.1016\/S1473-3099(21)00344-3 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"88713_CR27","doi-asserted-by":"publisher","first-page":"104811","DOI":"10.1016\/j.micinf.2021.104811","volume":"23","author":"PJ Hotez","year":"2021","unstructured":"Hotez, P. J., Nuzhath, T., Callaghan, T. & Colwell, B. COVID-19 vaccine decisions: considering the choices and opportunities. Microbes Infect. 23, 104811. https:\/\/doi.org\/10.1016\/j.micinf.2021.104811 (2021).","journal-title":"Microbes Infect."},{"key":"88713_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41467-022-28200-3","volume":"13","author":"LH Nguyen","year":"2022","unstructured":"Nguyen, L. H. et al. Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom. Nat. Commun. 13, 636. https:\/\/doi.org\/10.1038\/s41467-022-28200-3 (2022).","journal-title":"Nat. Commun."},{"key":"88713_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1001\/archinte.167.10.1041","volume":"167","author":"CL Bennett","year":"2007","unstructured":"Bennett, C. L. et al. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch. Intern. Med. 167, 1041\u20131049. https:\/\/doi.org\/10.1001\/archinte.167.10.1041 (2007).","journal-title":"Arch. Intern. Med."},{"key":"88713_CR30","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/s2214-109x(23)00490-4","volume":"12","author":"C Arsenault","year":"2024","unstructured":"Arsenault, C. et al. Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries. Lancet Glob Health. 12, e156\u2013e165. https:\/\/doi.org\/10.1016\/s2214-109x(23)00490-4 (2024).","journal-title":"Lancet Glob Health"},{"key":"88713_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ndt\/gfac307","volume":"38","author":"B Quiroga","year":"2023","unstructured":"Quiroga, B. et al. Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study. Nephrol. Dial Transpl. 38, 969\u2013981. https:\/\/doi.org\/10.1093\/ndt\/gfac307 (2023).","journal-title":"Nephrol. Dial Transpl."},{"key":"88713_CR32","doi-asserted-by":"publisher","first-page":"15098","DOI":"10.1038\/s41598-023-42406-5","volume":"13","author":"T Hamaya","year":"2023","unstructured":"Hamaya, T. et al. Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab. Sci. Rep. 13, 15098. https:\/\/doi.org\/10.1038\/s41598-023-42406-5 (2023).","journal-title":"Sci. Rep."},{"key":"88713_CR33","doi-asserted-by":"publisher","first-page":"ii40","DOI":"10.1093\/ndt\/gfad080","volume":"38","author":"M Windpessl","year":"2023","unstructured":"Windpessl, M. et al. Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis. Nephrol. Dial Transpl. 38, ii40\u2013ii49. https:\/\/doi.org\/10.1093\/ndt\/gfad080 (2023).","journal-title":"Nephrol. Dial Transpl."},{"key":"88713_CR34","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.54724\/lc.2022.e10","volume":"2","author":"SY Kim","year":"2022","unstructured":"Kim, S. Y. & Yeniova, A. \u00d6. Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 dashboard. Life Cycle. 2, e10. https:\/\/doi.org\/10.54724\/lc.2022.e10 (2022).","journal-title":"Life Cycle"},{"key":"88713_CR35","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda, N. et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl. J. Med. 385, 1078\u20131090. https:\/\/doi.org\/10.1056\/NEJMoa2110475 (2021).","journal-title":"N Engl. J. Med."},{"key":"88713_CR36","doi-asserted-by":"publisher","unstructured":"Lamprinou, M., Sachinidis, A., Stamoula, E., Vavilis, T. & Papazisis, G. COVID-19 vaccines adverse events: potential molecular mechanisms. Immunol. Res. 1\u201317. https:\/\/doi.org\/10.1007\/s12026-023-09357-5 (2023).","DOI":"10.1007\/s12026-023-09357-5"},{"key":"88713_CR37","doi-asserted-by":"publisher","unstructured":"Li, X. et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ 376 https:\/\/doi.org\/10.1136\/bmj-2021-068373 (2022). e068373.","DOI":"10.1136\/bmj-2021-068373"},{"key":"88713_CR38","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/oxfordjournals.ndt.a027900","volume":"13","author":"S Ozdemir","year":"1998","unstructured":"Ozdemir, S., Bakkaloglu, A. & Oran, O. Nephrotic syndrome associated with recombinant hepatitis B vaccination: a causal relationship or just a mere association? Nephrol. Dial Transpl. 13, 1888\u20131889. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a027900 (1998).","journal-title":"Nephrol. Dial Transpl."},{"key":"88713_CR39","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","volume":"6","author":"N Klomjit","year":"2021","unstructured":"Klomjit, N. et al. COVID-19 vaccination and glomerulonephritis. Kidney Int. Rep. 6, 2969\u20132978. https:\/\/doi.org\/10.1016\/j.ekir.2021.09.008 (2021).","journal-title":"Kidney Int. Rep."},{"key":"88713_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s0140-6736(03)14072-x","volume":"362","author":"AS Abeyagunawardena","year":"2003","unstructured":"Abeyagunawardena, A. S., Goldblatt, D., Andrews, N. & Trompeter, R. S. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 362, 449\u2013450. https:\/\/doi.org\/10.1016\/s0140-6736(03)14072-x (2003).","journal-title":"Lancet"},{"key":"88713_CR41","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","volume":"31","author":"N Yildiz","year":"2013","unstructured":"Yildiz, N. et al. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 31, 3309\u20133312. https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.004 (2013).","journal-title":"Vaccine"},{"key":"88713_CR42","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/ndt\/gfab215","volume":"36","author":"H Izzedine","year":"2021","unstructured":"Izzedine, H., Bonilla, M. & Jhaveri, K. D. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial? Nephrol. Dial Transpl. 36, 1565\u20131569. https:\/\/doi.org\/10.1093\/ndt\/gfab215 (2021).","journal-title":"Nephrol. Dial Transpl."},{"key":"88713_CR43","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2215\/CJN.01890221","volume":"16","author":"A Angeletti","year":"2021","unstructured":"Angeletti, A. et al. Vaccines and Disease relapses in children with nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 16, 937\u2013938. https:\/\/doi.org\/10.2215\/CJN.01890221 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"88713_CR44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.kint.2021.09.002","volume":"100","author":"NL Li","year":"2021","unstructured":"Li, N. L., Coates, P. T. & Rovin, B. H. COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation? Kidney Int. 100, 959\u2013965. https:\/\/doi.org\/10.1016\/j.kint.2021.09.002 (2021).","journal-title":"Kidney Int."},{"key":"88713_CR45","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.autrev.2020.102707","volume":"20","author":"C Rasmussen","year":"2021","unstructured":"Rasmussen, C. et al. Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun. Rev. 20, 102707. https:\/\/doi.org\/10.1016\/j.autrev.2020.102707 (2021).","journal-title":"Autoimmun. Rev."},{"key":"88713_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman, K. J., Lanes, S. & Sacks, S. T. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 13, 519\u2013523. https:\/\/doi.org\/10.1002\/pds.1001 (2004).","journal-title":"Pharmacoepidemiol Drug Saf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88713-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88713-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88713-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:35:24Z","timestamp":1739460924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88713-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88713"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88713-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5177"}}